FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

July 31 2018 A class 3 recall for sodium cromoglicate 2% w/v eye drops and Murine Hayfever Relief...

Effect of omega-3 on heart disease is negligible, finds Cochrane review

Effect of omega-3 on heart disease is negligible, finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

BLF highlights decline in stop smoking prescriptions

BLF highlights decline in stop smoking prescriptions

July 18 2018 There has been a 75% decline in stop smoking treatments being prescribed by GPs and...

Welsh National Survey includes OTC medicine purchases for first time

Welsh National Survey includes OTC medicine purchases for first time

June 28 2018 Over half the population in Wales has reported having bought an over the counter...

Recall issued for several own label glycerine and blackcurrant cough syrups

Recall issued for several own label glycerine and blackcurrant cough syrups

June 20 2018 A Class 2 Drug Recall has been issued for 15 batches of own-brand children’s...

  • FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    Tuesday, 31 July 2018 15:24
  • Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Thursday, 19 July 2018 10:21
  • BLF highlights decline in stop smoking prescriptions

    BLF highlights decline in stop smoking prescriptions

    Wednesday, 18 July 2018 17:32
  • Welsh National Survey includes OTC medicine purchases for first time

    Welsh National Survey includes OTC medicine purchases for first time

    Thursday, 28 June 2018 16:55
  • Recall issued for several own label glycerine and blackcurrant cough syrups

    Recall issued for several own label glycerine and blackcurrant cough syrups

    Wednesday, 20 June 2018 18:29

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

vapingFebruary 1 2016

A US study has found that adolescents who use e-cigarettes are more likely to start smoking tobacco cigarettes.

The study among looked at the smoking and vaping habits of 2,238 Hawaiian students with a mean age of 14.7 years, with a follow up one year later. Among those who had never smoked tobacco, those who said they had used e-cigarettes in the first questionnaire were more likely to have smoked cigarettes a year later.

There was no significant change in smoking habits among those who had said they had smoked tobacco at some point before the first survey and who had used e-cigarettes, compared to a year later.

The authors of the study, which appears in the BMJ publication Tobacco Control, conclude that their results and other findings suggest that “policies restricting adolescents’ access to e-cigarettes may have a rationale from a public health standpoint.”

Among the findings were:

  • 31% of the sample, overall, had used e-cigarettes by 2013, rising to 38% by 2014
  • 15% had smoked at least one cigarette in 2013, rising to 21% by 2014
  • 98% of those quizzed in the first wave of the survey had heard of e-cigarettes
  • 68% considered them to be healthier than smoking
  • among non-users of e-cigarettes and tobacco at the study outset, one in 10 had tried e-cigarettes by the second wave, while 2% had experimented with cigarettes, 4% had tried both.

Since October 2015, it has been illegal in the UK to sell e-cigarettes to people under the age of 18 years. E-cigarettes licensed as medicines will be expected to have a minimum age of use at 18 years. The newly licensed e-Voke electronic inhaler from Nicovations is contraindicated in children under 18 years.

Links:

BMJ announcement

TA Wills et al. ‘Longitudinal study of e-cigarette use and onset of cigarette smoking among high school students in Hawaii’. Tobacco Control. Published online first on January 25 2106

e-Voke SPC on MHRA

OTC News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...